0

Razoxane

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP21416671
CAS21416-67-1
Structure
MDL NumberMFCD00430424
Molecular Weight268.27
EC Number244-379-2
InChI KeyBMKDZUISNHGIBY-UHFFFAOYSA-N
Description>98% (HPLC)
SolubilityDMSO: 40 mg/mL
Assay>98% (HPLC)
Formsolid
Size5MG, 25MG
Storage Conditionsroom temp
1

A Controlled Prospective Trial of Adjuvant Razoxane in Resectable Colorectal Cancer

J M Gilbert, P C Cassell, H Ellis, C Wastell, K Hellmann, M G Evans, B J Stoodley

Recent Results Cancer Res. 1981;79:48-58.

PMID: 7029684

1

Combined Radiotherapy and Razoxane in the Treatment of Chondrosarcomas and Chordomas

Walter Rhomberg, Helmut Eiter, Franz Böhler, Susanne Dertinger

Anticancer Res. May-Jun 2006;26(3B):2407-11.

PMID: 16821624

1

Combined Razoxane and Radiotherapy for Melanoma Brain Metastases. A Retrospective Analysis

Walter Rhomberg, Helmut Eiter, Franz Boehler, Christoph Saely, Robert Strohal

J Neurooncol. 2005 Sep;74(3):295-9.

PMID: 16086112

1

Development and Validation of Stereo Selective Method for the Separation of Razoxane Enantiomers in Hydrophilic Interaction Chromatography

Ch Thirupathi, K Nagesh Kumar, G Srinivasu, Ch Lakshmi Narayana, Ch Parameswara Murthy

J Chromatogr Sci. 2018 Feb 1;56(2):147-153.

PMID: 29140426

1

Razoxane

D J Atherton

Clin Exp Dermatol. 1981 Nov;6(6):647-50.

PMID: 7341016

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode